Tourmaline Bio, Inc. (TRML)
NASDAQ: TRML · Real-Time Price · USD
47.74
+0.02 (0.04%)
At close: Sep 26, 2025, 4:00 PM EDT
47.69
-0.05 (-0.10%)
After-hours: Sep 26, 2025, 6:44 PM EDT

Tourmaline Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
1,230520532--
Market Cap Growth
167.60%-2.33%---
Enterprise Value
991238583--
Last Close Price
47.7420.2826.18--
PB Ratio
4.731.732.60--
P/TBV Ratio
4.741.732.60--
Debt / Equity Ratio
0.000.000.000.07-0.66
Quick Ratio
23.7028.9940.576.060.40
Current Ratio
24.6830.1841.766.100.40
Return on Equity (ROE)
-29.62%-28.99%-39.66%-549.77%-
Return on Assets (ROA)
-20.85%-21.60%-25.87%-266.29%-
Return on Capital (ROIC)
-21.42%-22.18%-26.60%-314.87%-
Earnings Yield
-7.20%-14.08%-7.91%--
FCF Yield
-7.02%-14.86%-5.29%--
Buyback Yield / Dilution
-53.98%-433.98%-441.28%91.94%-
Updated Aug 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q